Instant Dark Tea Alleviates Hyperlipidaemia in High-Fat Diet-Fed Rat: From Molecular Evidence to Redox Balance and Beyond

Si Qin, Zhilan He, Yuanjie Wu, Chaoxi Zeng, Zhibing Zheng, Haowei Zhang, Chenghao Lv, Yonggui Yuan, Haoren Wu, Jian‐Hui Ye, Zhonghua Liu, Meng ShiFrontiers in Nutrition 2022 · DOI

TL;DR

This study investigates how instant dark tea (IDT) combats hyperlipidemia in rats fed a high-fat diet (HFD). IDT not only improves key metabolic markers like cholesterol and blood glucose but also positively modulates liver gene expression related to lipid metabolism and significantly reshapes the gut microbiome, highlighting a multi-faceted approach to managing this metabolic disorder.

What Problem Does This Paper Address?

Hyperlipidemia, characterized by elevated levels of LDL cholesterol and triglycerides, is a major risk factor for chronic diseases like obesity, diabetes, and cardiovascular issues. While lifestyle interventions like diet are crucial, the underlying molecular mechanisms by which natural compounds can ameliorate hyperlipidemia are not always fully understood. Specifically, the authors aimed to elucidate the molecular mechanisms by which instant dark tea (IDT), a convenient form of dark tea known for its health benefits, impacts hyperlipidemia, particularly focusing on its effects on liver gene expression and the gut microbiome.

Methods

The researchers employed a multi-omics approach using a rat model.

  • Animal Model: Sprague Dawley rats were fed a high-fat diet (HFD) for 12 weeks to induce hyperlipidemia and obesity. They were then treated with different doses of IDT or simvastatin (a control drug).
  • Biochemical Analysis: Serum levels of total cholesterol (TC), triglycerides (TG), LDL-C, HDL-C, and blood glucose were measured. Liver oxidative stress markers (ROS, MDA, SOD, CAT, GSH-Px) were also assessed.
  • Molecular Analysis (Omics):
    • Gene Expression (qRT-PCR): The expression of key genes involved in lipid metabolism (lipogenesis and oxidation) and glucose glycolysis in the liver was quantified.
  • Gut Microbiome Sequencing (16S rRNA): The composition and diversity of the gut microbiota were analyzed using 16S rRNA gene sequencing.
  • Histological Analysis: Liver tissue morphology was examined using H&E staining to assess fat accumulation and cellular damage.
  • Correlation Analysis: Spearman's correlation was used to link gut microbiota composition with biochemical parameters and gene expression data.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • IDT as a Multi-Target Intervention: The study reveals that IDT doesn't just target one aspect of hyperlipidemia. It simultaneously improves lipid profiles, reduces oxidative stress, modulates key metabolic genes in the liver, and positively alters the gut microbiome. This suggests a holistic approach to managing metabolic disorders.
  • Gut Microbiome as a Key Mediator: The significant changes observed in the gut microbiota, particularly the increase in beneficial bacteria like Akkermansia and the decrease in potentially harmful ones, strongly suggest that the gut microbiome plays a crucial role in mediating IDT's beneficial effects. This opens avenues for microbiome-targeted therapies.
  • Identification of Potential Biomarkers: The correlation analysis identified specific gut bacterial genera (Akkermansia, Clostridiales, Lachnospiraceae, etc.) that are significantly associated with oxidative stress and lipid metabolism markers. These could serve as valuable biomarkers for predicting or monitoring treatment response.
  • Molecular Mechanisms Unveiled: By examining gene expression, the study provides molecular evidence for how IDT works, showing its impact on genes controlling fatty acid uptake, lipid oxidation, and glucose metabolism. This moves beyond simply observing phenotypic changes.

Key Results

  • Metabolic Improvements: IDT treatment significantly reduced body weight, serum TC, TG, LDL-C, and blood glucose, while increasing HDL-C in HFD-fed rats.
  • Reduced Oxidative Stress: IDT administration led to decreased levels of MDA and ROS and increased levels of antioxidant enzymes (SOD, CAT, GSH-Px) and the transcription factor Nrf2 in the liver.
  • Gene Expression Modulation: IDT significantly impacted the expression of genes involved in lipid metabolism, including downregulating lipogenesis genes (e.g., FABP1, FABP3, SCD1) and upregulating lipid oxidation genes (e.g., PPARγ). It also modulated glycolysis genes (Gck, ENO2).
  • Gut Microbiota Shifts: IDT significantly altered the gut microbial community, suppressing the HFD-induced increase in Proteobacteria and Firmicutes. It boosted beneficial bacteria like Akkermansia and Rikenellaceae_RC9_gut_group while decreasing harmful bacteria like Ruminococcaceae_UCG-005 and Ruminiclostridium_9.
  • Correlation Findings: Several gut genera were found to be significantly correlated with various metabolic and oxidative stress parameters, highlighting their potential role as biomarkers.

Limitations and Future Work

  • Germ-Free and Antibiotic-Treated Mice: The authors suggest that future research should involve germ-free mice or antibiotic-treated mice to further elucidate the precise mechanisms by which the gut microbiota mediates IDT's effects.
  • Bioconversion of Metabolites: Determining how the host and microbiota bioconvert IDT's components and whether these metabolites contribute to its functionality is highlighted as an area for future investigation.
  • Dose-Response Nuances: While IDT showed benefits, the study noted that there wasn't a clear dose-dependent trend for all parameters, suggesting that even lower doses might be effective, or that other factors are at play. Further studies could refine optimal dosing.
  • Human Translation: While this study provides strong evidence in a rat model, future work would ideally translate these findings to human clinical trials to confirm IDT's efficacy and safety in humans.

Summary updated

Abstract

Instant dark tea (IDT) is a new product gaining increasing attention because it is convenient and can endow significant health benefit to consumers, which is partially attributed to its high concentration of functional ingredients. However, the molecular mechanism underlying its regulatory effect on hyperlipidaemia is rarely studied. In this study, we performed omics and molecular verification in high-fat diet (HFD)-fed rat, aiming to reveal the mechanism and provide molecular evidence. The results showed that the major bioactive components in IDT were 237.9 mg/g total polysaccharides, 336.6 mg/g total polyphenols, and 46.9 mg/g EGCG. Rats fed with IDT (0.27-0.54 g/kg for 12 weeks) significantly reduced the body weight and TC, TG, LDL-C, blood glucose, and MDA and induced the level of serum HDL-C and also the levels of liver SOD, CAT, GSH-Px, and Nrf2, compared to HFD group. For molecular mechanism study, HIDT feeding had significant impact on the gene expressions of biomarkers in lipogenesis (<i>FABP, CD36, SCD1, Cyp4a1</i>, and <i>Kcnn2</i>), lipid oxidation (<i>PPAR</i>γ), and glucose glycolysis (<i>Gck</i> and <i>ENO2</i>) in liver tissue. Moreover, gut microbiome study found that rats fed with IDT dramatically modified the gut microbial species at the family level, such as suppressing the increase abundance of Proteobacteria and Firmicutes induced by HFD. HIDT significantly boosted the relative composition of beneficial bacterium <i>Akkermansia</i> and <i>Rikenellaceae_RC9_gut_group</i> and decreased the relative abundance of the harmful bacterium <i>Ruminococcaceae_UCG-005</i> and <i>Ruminiclostridium_9</i>, compared to HFD (<i>p</i> < 0.01). Correlation analysis between microbiome and animal indicators found that seven genera including <i>Akkermansia, Clostridiales, Lachnospiraceae, Lachnospiraceae_UCG-010, Ruminiclostridium_9, Ruminococaceae-UCG-005</i>, and <i>Ruminocuccus_1</i> were found as potential biomarkers that were strongly correlated with oxidative stress and metabolism genes. For instance, <i>Ruminococcaceae_UCG-005</i> was significantly correlated with body weight, TG, HDL-C, Nfr2, <i>FABP3, SCD1, Cyp4a1</i>, and <i>Kcnn2</i>. Collectively, the above data obtained in this study had provided the primary molecular evidence for the molecular mechanism and brought in novel insights based on omics for the regulatory effect of IDT on hyperlipidaemia.
BibTeX
@inproceedings{qin2022instant,
  author = {Si Qin and Zhilan He and Yuanjie Wu and Chaoxi Zeng and Zhibing Zheng and Haowei Zhang and Chenghao Lv and Yonggui Yuan and Haoren Wu and Jian‐Hui Ye and Zhonghua Liu and Meng Shi},
  title = {{Instant Dark Tea Alleviates Hyperlipidaemia in High-Fat Diet-Fed Rat: From Molecular Evidence to Redox Balance and Beyond}},
  booktitle = {Frontiers in Nutrition},
  year = {2022},
  doi = {10.3389/fnut.2022.819980},
}
Figure